1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

25 Sep 2023
Admin
News Article

The University of Queensland and Oxford Nanopore Technologies Announce Research Partnership

The University of Queensland has joined forces with Oxford Nanopore Technologies in a collaborative effort aimed at expediting research related to the quality control testing of mRNA vaccines.

Under this partnership, researchers at the University of Queensland, known as BASE researchers, will leverage the latest advancements in nanopore-based sequencing technology to enhance performance and significantly reduce the time required to assess the quality attributes of mRNA vaccines. This innovative approach is poised to simplify and bolster the quality assurance processes for mRNA-based vaccines and therapeutics, benefiting global manufacturing standards.

Currently, the analysis of mRNA vaccines and therapies relies on a multitude of diverse methods that can be both time-consuming and intricate, often incurring substantial costs. Furthermore, some of these methods may become outdated as the field advances.

By adopting Oxford Nanopore Technologies sequencing, the research team can directly examine each individual mRNA vaccine molecule as it traverses a protein nanopore. This real-time analysis provides an instantaneous and precise measurement of the mRNA sequence's identity and integrity, offering a cutting-edge solution for quality control.

This partnership has the potential to reshape the landscape of mRNA-based medical products, ensuring their quality, safety, and effectiveness on a global scale.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!